Insights into the use of Ketamine for Depression

Last month the F.D.A. approved the use of esketamine as an antidepressant for individuals that have tried at least two other treatments for depression. Esketamine is the first ketamine-derived medicine, meaning that it is molecularly part of ketamine. At NMHIC, we have been aware of the use of ketamine for depression, but for a majority of the population this is …

Event Blog: NMHIC at the State Innovation Model Collaborative Learning Session

Sarah Beary and Sam Hubley recently spoke at the State Innovation Model (SIM) Collaborative Learning Session in Broomfield, CO. The SIM is a state-wide grant from the Center for Medicare and Medicaid Innovation that focuses on increasing access for all Coloradoans to integrated behavioral health and primary care services. NMHIC received an invitation to present at the Collaborative Learning Session …